DOCSLIB.ORG

2021 SELECT EX FORMULARY the Following Is a List of the Most Commonly Prescribed Brand and Generic Medications

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2021 SELECT EX FORMULARY the Following Is a List of the Most Commonly Prescribed Brand and Generic Medications 2021 SELECT EX FORMULARY The following is a list of the most commonly prescribed brand and generic medications. It represents an abbreviated version of the formulary list that is at the core of your prescription drug benefit plan. The list is not all-inclusive and does not guarantee coverage. Some preferred medications overlap with other clinical programs and may not be covered. In addition to drugs on this list, the majority of generic medications are covered under your plan and you are encouraged to ask your doctor to prescribe generic drugs whenever appropriate. Search complete formulary drug information at elixirsolutions.com. PLEASE NOTE: Preferred brand drugs may move to non-preferred status if a generic version becomes available during the year. Any medication approved to enter the market will not be covered until reviewed by Elixir. Not all drugs listed are covered by all prescription drug benefit programs. For specific questions about your coverage, please visit elixirsolutions.com. A B CILOXAN OINTMENT digoxin abacavir tablet balsalazide CIMDUO diltiazem ER (except generics for abacavir-lamivudine BAQSIMI cinacalcet CARDIZEM LA) ABILIFY MAINTENA [INJ] BASAGLAR [INJ] ciprofloxacin dimethyl fumarate DR* abiraterone* BD ULTRAFINE INSULIN SYRINGES ciprofloxacin-dexamethasone diphenoxylate-atropine acetic acid & NEEDLES citalopram dipyridamole ER-aspirin acitretin BELBUCA CITRANATAL divalproex sodium ACUVAIL BELSOMRA clarithromycin divalproex sodium ER acyclovir capsule, tablet benzonatate (except NDCs: clarithromycin ER DIVIGEL adapalene 69336012615, 69499032915) CLENPIQ donepezil ADEMPAS * benzoyl peroxide CLIMARA PRO DOPTELET* ADVAIR HFA BESIVANCE clindamycin dorzolamide ADYNOVATE* BETASERON [INJ]* clindamycin gel (except NDC: dorzolamide-timolol AFINITOR* BETHKIS* 68682046275) DOVATO AIMOVIG [INJ] BETIMOL clindamycin solution doxazosin AJOVY [INJ] BETOPTIC S clindamycin-benzoyl peroxide doxepin albuterol inhalation solution bicalutamide clobazam doxycycline hyclate 20 mg albuterol sulfate CFC-free aerosol BIDIL clobetasol cream, foam, gel, lotion, doxycycline hyclate capsule ALECENSA* BIKTARVY ointment, shampoo dronabinol alendronate bosentan* clonazepam DUAVEE alfuzosin ER BOSULIF* clopidogrel duloxetine aliskiren BREO ELLIPTA clotrimazole DUPIXENT [INJ]* allopurinol BREZTRI AEROSPHERE clozapine DUREZOL alosetron BRILINTA codeine-acetaminophen DUROLANE [INJ]* ALPHAGAN P brimonidine colchicine tablet dutasteride alprazolam bromfenac colesevelam dutasteride-tamsulosin ALUNBRIG* BRYHALI COMBIGAN DYMISTA ambrisentan budesonide capsule COMBIPATCH amiloride budesonide ER COMPLERA E amlodipine budesonide inhalation suspension COPAXONE [INJ]* econazole amlodipine-atorvastatin buprenorphine transdermal COPIKTRA* eletriptan amlodipine-olmesartan buprenorphine-naloxone sublingual CORLANOR ELIGARD [INJ]* amlodipine-telmisartan bupropion CORTIFOAM ELIQUIS amlodipine-valsartan bupropion ER (except bupropion COSENTYX [INJ]* EMGALITY [INJ] amlodipine-valsartan-HCTZ ER tablet 450 mg) CREON CRINONE EMVERM amoxicillin BYSTOLIC cromolyn sodium ENBREL [INJ]* amoxicillin-clavulanate cyclobenzaprine (except ENDOMETRIN amphetamine-dextroamphetamine C cyclobenzaprine tablet 7.5 mg) entacapone mixed salts CABOMETYX* entecavir amphetamine-dextroamphetamine calcipotriene ointment, solution D ENTRESTO mixed salts ER calcitonin-salmon DALIRESP EPCLUSA* ANDRODERM calciumacetate darifenacin ER EPIDUO ANNOVERA candesartan DESCOVY epinephrine auto-injector [INJ] ANORO ELLIPTA candesartan-HCTZ desonide EPIPEN [INJ] aprepitant carbamazepine desoximetasone EPIPEN JR [INJ] ARANESP [INJ]* carbamazepine ER desvenlafaxine ER EPISIL aripiprazole carbidopa-levodopa dexamethasone ERIVEDGE * armodafinil carbidopa-levodopa ER DEXCOM CONTINUOUS GLUCOSE ERLEADA* ARNUITY ELLIPTA carbidopa-levodopa-entacapone MONITORING SYSTEM erythromycin atazanavir carvedilol DEXILANT erythromycin solution atenolol carvedilol phosphate ER diazepam erythromycin-benzoyl peroxide atomoxetine cefdinir diazepam rectal gel erythromycins atorvastatin cefprozil diclofenac ESBRIET* ATRIPLA cefuroxime axetil diclofenac sodium escitalopram AUBAGIO* celecoxib diclofenac sodium gel 1% esomeprazole AUSTEDO* cephalexin diclofenac sodium solution estradiol azelaic acid gel CERDELGA* diclofenac sodium-misoprostol estradiol-norethindrone azelastine CEREZYME [INJ]* dicloxacillin eszopiclone azithromycin CETROTIDE [INJ]* dicyclomine ethinyl estradiol- drospirenone AZOPT cholestyramine DIFICID ethinyl estradiol-drospirenone-levomefolate ciclopirox ethinyl estradiol-etonogestrel [INJ] - Injectable Drug | * denotes a Specialty Drug | ALL CAPS are brand and lower case are generic Elixir • 2021 Select EX Formulary | 1 2021 SELECT EX FORMULARY Continued ethinyl estradiol-levonorgestrel H linezolid neomycin-polymyx in B-bacitracin- ethinyl estradiol-norelgestromin HARVONI* LINZESS hydrocortisone ethinyl estradiol-norethindrone acetate HUMIRA [INJ]* liothyronine neomycin-polymyx in B-dexamethasone ethinyl estradiol-norethindrone acetate-iron HUMULIN R U-500 [INJ] lisinopril neomycin-polymyx in B-hydrocortisone ethinyl estradiol-norgestimate hydrochlorothiazide lisinopril-HCTZ NEUPRO ethosuximide hydrocodone ER LO LOESTRIN FE NEVANAC EUCRISA hydrocodone-acetaminophen LOKELMA NEXLETOL EUFLEXXA [INJ]* hydrocortisone loperamide NEXLIZET EVAMIST hydrocortisone butyrate cream, lotion, lorazepam niacin ER everolimus* ointment, solution losartan nifedipine ER EVOTAZ hydrocortisone enema losartan-HCTZ NINLARO* ezetimibe hydromorphone loteprednol nitrofurantoin ezetimibe-simvastatin hydromorphone ER lovastatin nitroglycerin sublingual spray luliconazole nitroglycerin sublingual F I LUMIGAN NIVESTYM [INJ]* famotidine ibandronate LUPRON DEPOT [INJ]* NORDITROPIN [INJ]* FARXIGA IBRANCE* LYNPARZA* NORVIR FASENRA [INJ]* ibuprofen NOVOEIGHT* fenofibrate (except fenofibrate tablet ILEVRO M NOVOLIN 70/30 [INJ] 120 mg) imatinib mesylate* MAXIDEX NOVOLIN N [INJ] fenofibric acid DR imiquimod MAYZENT* NOVOLIN R [INJ] fentanyl transdermal IMVEXXY meclizine NOVOLOG [INJ] fentanyl transmucosal lozenge INBRIJA medroxyprogesterone NOVOLOG MIX 70/30 [INJ] FIASP [INJ] INGREZZA* megestrol acetate NUBEQA* FINACEA FOAM ipratropiuminhalation solution meloxicam NUCALA [INJ]* finasteride ipratropium-albuterol inhalation solution memantine NUCYNTA FIRAZYR [INJ]* irbesartan mesalamine DR NUCYNTA ER FLOVENT DISKUS irbesartan-HCTZ mesalamine ER NUEDEXTA FLOVENT HFA IRESSA* mesalamine suppository NURTEC ODT fluconazole ISENTRESS mesalamine suspension NUWIQ* fludrocortisone isosorbide dinitrate (except isosorbide metformin nystatin flunisolide dinitrate 40 mg) metformin ER (except generics for fluocinonide (except fluocinonide isosorbide mononitrate FORTAMET and GLUMETZA) O cream 0.1%) itraconazole methadone OCREVUS [INJ]* fluorouracil cream 5% ivermectin methoxsalen ODEFSEY fluorouracil solution methylphenidate ODOMZO* fluoxetine (except fluoxetine tablet 60 mg, J methylphenidate ER OFEV* fluoxetine tablet [generics for SARAFEM]) JANUMET methylprednisolone ofloxacin fluticasone JANUMET XR metoclopramide ofloxacin otic fluticasone/salmeterol JANUVIA metolazone olanzapine fluvastatin JARDIANCE metoprolol succinate ER olmesartan FML FORTE JIVI* metoprolol tartrate olmesartan-amlodipine-HCTZ FML S.O.P. metronidazole olmesartan-HCTZ folic acid K minocycline olopatadine FORTEO [INJ]* KESIMPTA [INJ]* MIRENA omega-3 acid ethyl esters fosinopril ketoconazole cream 2% mirtazapine omeprazole fosinopril-HCTZ ketoconazole shampoo 2% mometasone OMNIPOD DASH INSULIN INFUSION furosemide ketorolac montelukast PUMP KISQALI* morphine OMNIPOD INSULIN INFUSION PUMP G KISQALI FEMARA CO-PACK* morphine ER ondansetron gabapentin KOGENATE FS* morphine suppository ONETOUCH ULTRA STRIPS AND KITS galantamine KOVALTRY* MOVANTIK ONETOUCH VERIO STRIPS AND KITS galantamine ER KYLEENA moxifloxacin ONEXTON GELSYN-3 [INJ]* MULPLETA* ONZETRA XSAIL GENOTROPIN [INJ]* L MULTAQ OPSUMIT * gentamicin lactulose solution mupirocin ointment ORACEA GENVOYA lamivudine MUSE ORALAIR GILENYA* lamotrigine MYDAYIS ORENITRAM* Glatiramer [INJ]* glimepiride lamotrigine ER MYRBETRIQ ORFADIN* glipizide ER lansoprazole ORILISSA glipizide-metformin LASTACAFT N oseltamivir GLUCAGEN HYPOKIT [INJ] latanoprost nadolol OTEZLA* GLUCAGON EMERGENCY KIT [INJ] LATUDA NAFTIN OVIDREL [INJ]* GLYXAMBI levalbuterol tartrate CFC-free aerosol naloxone injection [INJ] oxazepam GONAL-F [INJ]* LEVEMIR [INJ] NAMZARIC oxcarbazepine GRALISE levetiracetam naproxen (except naproxen CR or OXTELLAR XR granisetron levetiracetam ER naproxen suspension) oxybutynin GRASTEK levocarnitine naratriptan oxybutynin ER guanfacine ER levocetirizine NARCAN NASAL SPRAY oxycodone GVOKE [INJ] levofloxacin nateglinide oxycodone-acetaminophen levothyroxine NAYZILAM OZEMPIC [INJ] lidocaine-prilocaine [INJ] - Injectable Drug | * denotes a Specialty Drug | ALL CAPS are brand and lower case are generic Elixir • 2021 Select EX Formulary | 2 2021 SELECT EX FORMULARY Continued P REYVOW telmisartan VIOKACE pantoprazole RHOPRESSA telmisartan-HCTZ VISTOGARD paroxetine HCl ribavirin TEMIXYS VOSEVI* paroxetine HCl ER RINVOQ* terazosin VRAYLAR paroxetine mesylate risedronate terbinafine tablet VUMERITY* PAZEO risperidone testosterone gel (except authorized VYVANSE peg 3350-electrolytes rivastigmine generics for TESTIM and penicillin VK rivastigmine transdermal VOGELXO) testosterone solution W PENTASA rizatriptan tetrabenazine warfarin PERFOROMIST ROCKLATAN tetracycline wixela inhub PERSERIS [INJ] ropinirole tiagabine phenobarbital ropinirole ER timolol maleate
Load more

Recommended publications
  • Azelaic Acid
    Azelaic Acid (FINACEA) Topical Foam 15% National Drug Monograph August 2016 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The purpose of VA PBM Services drug monographs is to provide a focused drug review for making formulary decisions. Updates will be made when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. FDA Approval Information Description/Mechanism of Azelaic acid is a naturally occurring C9-dicarboxylic acid that is found in plants Action (such as whole grain cereals), animals and humans. Azelaic acid has antiinflammatory, antioxidative and antikeratinizing effects. In rosacea skin, azelaic acid decreases cathelicidin levels and kallikrein 5 (KLK5) activity and possibly inhibits toll-like receptor 2 (TLR2) expression.1 A 15% gel formulation has been marketed for rosacea, and 20% cream has been available for acne vulgaris. The newer foam formulation consists of an oil- in-water emulsion and was designed to have a higher lipid content than the gel for dry and sensitive skin. Indication(s) Under Review Topical treatment of inflammatory papules and pustules of mild to moderate in This Document rosacea. Dosage Form(s) Under Foam, 15% Review REMS REMS No REMS Postmarketing Requirements See Other Considerations for additional REMS information Pregnancy Rating Category B Executive Summary Efficacy There have been no head-to-head trials comparing the foam and gel formulations of azelaic acid in terms of safety, tolerability and efficacy in the treatment of papulopustular (PP) rosacea.. In two major randomized clinical trials, azelaic acid foam produced small benefits over vehicle foam in achieving Investigator’s Global Assessment (IGA) treatment success (NNTs of 9.2 and 11.5) and in reducing inflammatory lesion counts.
    [Show full text]
  • CVS Formulary Drug Listing
    January 2021 Updated 11/01/2020 Performance Drug List - Standard Control The CVS Caremark® Performance Drug List - Standard Control is a guide within select therapeutic categories for clients, plan members and health care providers. Generics should be considered the first line of prescribing. If there is no generic available, there may be more than one brand-name medicine to treat a condition. These preferred brand-name medicines are listed to help identify products that are clinically appropriate and cost-effective. Generics listed in therapeutic categories are for representational purposes only. This is not an all-inclusive list. This list represents brand products in CAPS, branded generics in upper- and lowercase Italics, and generic products in lowercase italics. PLAN MEMBER HEALTH CARE PROVIDER Your benefit plan provides you with a prescription benefit program Your patient is covered under a prescription benefit plan administered administered by CVS Caremark. Ask your doctor to consider by CVS Caremark. As a way to help manage health care costs, prescribing, when medically appropriate, a preferred medicine from authorize generic substitution whenever possible. If you believe a this list. Take this list along when you or a covered family member brand-name product is necessary, consider prescribing a brand name sees a doctor. on this list. Please note: Please note: • Your specific prescription benefit plan design may not cover • Generics should be considered the first line of prescribing. certain products or categories, regardless of their appearance in • The member's prescription benefit plan design may alter coverage this document. Products recently approved by the U.S. Food and of certain products or vary copay1 amounts based on the condition Drug Administration (FDA) may not be covered upon release being treated.
    [Show full text]
  • Supply Issues Update for Primary and Secondary Care: September 2019
    COMMERCIAL-SENSITIVE Supply Issues Update for Primary and Secondary Care: September 2019 This report has been produced by the Department of Health and Social Care (DHSC) Medicine Supply Team. We aim to update this report monthly to provide an update on current primary and secondary care medicine supply issues that we are working on. This information is confidential to the NHS; please do not upload to websites in the public domain. Please do share with relevant colleagues and networks. Where it has been stated ‘a clinical memo from UKMI will be published on the SPS website’, this will be found at the following URL: https://www.sps.nhs.uk/category/shortages-discontinuations-and-expiries/ Acetylcholine Chloride (Miochol-E) 20mg Contents powder and solvent for irrigation ..................8 New Issues ............................................................. 3 Aciclovir 500mg/1g injection .........................8 Injectables ......................................................... 3 Amikacin 500mg/2ml injection ......................8 Diamorphine 5mg injection ........................... 3 Emerade 500 microgram and 300 microgram Adrenaline 1 in 1000, 1ml ampoules ............. 4 adrenaline auto-injector (AAI) devices ..........8 Lanoxin (digoxin) 250mcg/ml injection ......... 4 EpiPen and EpiPen Junior ..............................9 Sayana Press (medroxyprogesterone acetate Erwinase injection ..........................................9 104mg) injection ............................................ 5 Haloperidol 5mg/ml injection ........................9
    [Show full text]
  • Florida Medicaid Brand Drug Preferred List*
    FLORIDA MEDICAID BRAND DRUG PREFERRED LIST* Brand Name Generic Name Advair Diskus for inhalation fluticasone/salmeterol diskus Aggrenox capsules aspirin/dipyridamole Albenza tablets albendazole Androgel gel pack/pump** testosterone Avelox tablets** moxifloxacin Azactam vials aztreonam Benicar/Benicar-HCT tablets** olmesartan/olmesartan-HCTZ Bicnu vials carmustine Biltricide tablets praziquantel Butrans patch** buprenorphine transdermal Catapres TTS patch clonidine patch ER Cellcept suspension mycophenolate mofetil Cipro suspension (250mg/5ml & 500mg/5ml) ciprofloxacin Copaxone syringes 20mg glatiramer accetate/Glatopa Derma-Smoothe-FS oil fluocinolone 0.01% oil Differin cream and lotion adapalene erythromycin ethylsuccinate E.E.S. 200mg/5ml suspension - New addition suspension Elidel 1% cream pimecrolimus Emend capsules aprepitant Exelon patch rivastigmine transdermal Finacea GEL 15% azelaic acid Focalin XR capsules dexmethylphenidate hcl Gleevec tablets imatinib Mesylate Glyset tablets miglitol Humalog vial insulin lispro vial Kitabis Pak tobramycin pak Lamictal Dose Pak lamotrigine dose pak Lescol capsules / Lescol XL tablets** fluvastatin ER Letairis tablets** ambrisentan Lialda 1.2g tablets** mesalamine 1.2 g Lotemax 0.5% drops - New addition loteprednol 0.5% drops Makena single dose vial & auto inj** hydroxyprogesterone caproate vial Mephyton tablets phytonadione tablets Micardis and Micardis HCT tablets** telmisartan and telmisartan HCT Natroba suspension spinosad Norvir tablets ritonavir tablets Prevacid ODT lansoprazole ODT Proair
    [Show full text]
  • A Concise Guide to Treating Painful Oral Lesions
    Drugs Used to Treat Osteoporosis and Bone Cancer Perio & Implant Centers The Team for of the Monterey Bay (831) 648-8800 Jochen P. Pechak, DDS, MSD in Silicon Valley (408) 738-3423 Which May Cause Osteonecrosis of the Jaws mobile: www.DrPechakapp.com he many bisphosphonates and monoclonal antibodies which are used to treat osteoporosis and bone cancer often web: GumsRus.com causeDrugsDrugs osteonecrosis Used Used of the to jaws.to Treat AsTreat dental clinicians,Osteoporosis Osteoporosis it is important that and andwe are Bone awareBone of this Cancers Cancers side effect before Ttreating our patients who are taking these drugs. The tables below summarize these drugs, the route these drugs are administered, andWhich Whichtheir likelihood May May of causing Cause Cause osteonecrosis Osteonecrosis Osteonecrosis of the jaws as reported byof of Dr. the theRobert Jaws JawsMarx at the University of Miami Division of Oral and Maxillofacial Surgery. PDL tm Osteoporosis Drugs Drugs Osteoporosis Used to Treat Drugs Osteoporosis PerioDontaLetter Jochen P. Pechak, DDS, MSD, Periodontics and Implant Dentistry Spring DrugDrug ClassificationClassification ActionAction DoseDose RouteRoute %% of of ReportedReported CasesCases of of OsteonecrosisOsteonecrosis AlendronateAlendronate BisphosphonateBisphosphonate OsteoclastOsteoclast 7070 mg/wk mg/wk OralOral 8282%% From Our Office A Concise Guide to Treating (Fosamax(Fosamax ToxicityToxicity to Yours... Generic)Generic) Painful Oral Lesions ResidronateResidronate BisphosphonateBisphosphonate OsteoclastOsteoclast 3535 mg/wk mg/wk OralOral 1%1% As dentists specializing in treat- (Actonel Toxicity (Actonel Toxicity ment of diseases of the oral cavity atients present frequently with Treating Cold Sores Atelvia)Atelvia) and associated structures, we are painful oral lesions. They are often also called upon to treat pain- IbandronateIbandronate BisphosphonateBisphosphonate OsteoclastOsteoclast 150150 mg/mos mg/mos OralOral 1%1% usually not serious, but patients And Canker Sores (Boniva) Toxicity IV ful oral lesions in the mouth.
    [Show full text]
  • Making an Elderberry Syrup Or Elixir
    Making an Elderberry Syrup or Elixir Herbal syrups are water extractions of herbs (usually decoctions—see below) that are concentrated with a sweetener (preferably organic white sugar or raw honey). This sweetener provides a bit of nutritional support as a carbohydrate and also acts as a preservative. The concentration of sugar is particularly important when making syrups and elixirs; when in water, sugar acts as a food source for micro-organisms (especially molds and yeasts). However, at a high enough concentration, the sugar actually restricts the growth ability of micro-organisms. So we are aiming to get our syrup to be saturated enough to preserve, but not so saturated that the sugar overwhelms the liquid and causes crystallization. When preparing a syrup, one of the following ratios should be used: 1 part decoction : 1 part sweetener 1 part decoction : 2 parts sweetener I tend to follow the 1 part water : 1 part sweetener suggestion, as the 1 : 2 ratio is too sweet for me. But I have access to a refrigerator, which will also help with preservation. If you are keeping your syrup at room temperature, the 1:2 ratio is best. Syrups are a great, palatable method for delivery of herbal medicines (especially for children), and are also a great way to mask the flavor of less tasty tinctures--just combine the tincture and the syrup and you get the medicinal benefits of both. Preserving syrups with honey is also a great way to combine the medicinal benefits of the honey with the herbs that are being used. Do not give syrups preserved with honey to children under the age of one.
    [Show full text]
  • Slang Terms and Jargon Can Cause Medication Errors
    Volume 19, Number 10 November/December 2005 Drugs & Therapy B � U � L � L � E � T � I � N MEDICATION SAFETY FORMULARY UPDATE The Pharmacy and Therapeutics Slang terms and jargon can Committee met October 18, 2005. 4 products were added in the Formulary cause medication errors and 2 were deleted. 1 dosage form was evaluated and designated nonformu- his month “Magic Mouthwash” ents. An allergy screen would not be lary and not available, and 2 drugs T was deleted from the Formulary done, unless the individual ingredients were evaluated, but not added. Criteria (see Formulary Update). The P&T are appreciated. for use were modifi ed for 3 drugs. Committee took this action for medica- Magic Mouthwash will no longer be tion safety reasons. This continues the dispensed at Shands UF because there ◆ ADDED policy of not allowing the use of non- is no evidence that it works better than specifi c terms for mixtures that have a plain saline rinse. Clozapine Tablets traditionally been used. This action follows the banning of (generic by IVAX) Terms like “Magic Mouthwash” are the term “Butt Paste” several years Glutaraldehyde 0.6% Solution slang, jargon, or coined phrases for ago. Like Magic Mouthwash, Butt Paste (compounded) mixtures that have a specifi c purpose. is a nonspecifi c mixture of ingredients. Levofl oxacin In this instance, the “magic” is pain The “Butt Paste” mixture contained (Levaquin® by Ortho McNeil)* reduction in patients who have muco- Questran Light® (cholestyramine) in sitis of the mouth. Mucositis is a very Aquaphor®. The theory is that the cho- Ondansetron Tablets ® painful condition in patients receiving lestyramine binds bile acids that may (Zofran by GlaxoSmithKline) aggressive cytotoxic chemotherapy.
    [Show full text]
  • Pharmacy Manual Supplemental Policies, Procedures and Regulations
    Last revision date: 12.17.2020 Pharmacy Manual Supplemental Policies, Procedures and Regulations Prepared by: Elixir 800-361-4542 ELIXIRSOLUTIONS.COM 2181 E. Aurora Road, Suite 201 | Twinsburg, OH 44087 Copyright © 2020, Elixir. All rights reserved. Version 41 *This page was intentionally left blank* 1 Table of Contents PHARMACY MANUAL INTRODUCTION......................................................................................................................... 5 GENERAL INFORMATION ............................................................................................................................................. 5 PROPRIETARY AND CONFIDENTIAL .................................................................................................................. 5 ADVERTISING REQUESTS .............................................................................................................................. 6 CONTACT INFORMATION / WHERE TO GET HELP ...................................................................................................... 6 NETWORK ENROLLMENT FORM AND CREDENTIALING GUIDELINES ....................................................................... 6 APPLYING FOR PARTICIPATION ...................................................................................................................... 6 CREDENTIALING AND RECREDENTIALING GUIDELINES ....................................................................................... 7 PROVIDER AND MEMBER SERVICE STANDARDS .....................................................................................................
    [Show full text]
  • Aetna Formulary Exclusions Drug List
    Covered and non-covered drugs Drugs not covered – and their covered alternatives 2020 Advanced Control Plan – Aetna Formulary Exclusions Drug List 05.03.525.1B (7/20) Below is a list of medications that will not be covered without a Key prior authorization for medical necessity. If you continue using one of these drugs without prior approval, you may be required UPPERCASE Brand-name medicine to pay the full cost. Ask your doctor to choose one of the generic lowercase italics Generic medicine or brand formulary options listed below. Preferred Options For Excluded Medications1 Excluded drug name(s) Preferred option(s) ABILIFY aripiprazole, clozapine, olanzapine, quetiapine, quetiapine ext-rel, risperidone, ziprasidone, VRAYLAR ABSORICA isotretinoin ACANYA adapalene, benzoyl peroxide, clindamycin gel (except NDC^ 68682046275), clindamycin solution, clindamycin-benzoyl peroxide, erythromycin solution, erythromycin-benzoyl peroxide, tretinoin, EPIDUO, ONEXTON, TAZORAC ACIPHEX, esomeprazole, lansoprazole, omeprazole, pantoprazole, DEXILANT ACIPHEX SPRINKLE ACTICLATE doxycycline hyclate capsule, doxycycline hyclate tablet (except doxycycline hyclate tablet 50 mg [NDC^ 72143021160 only], 75 mg, 150 mg), minocycline, tetracycline ACTOS pioglitazone ACUVAIL bromfenac, diclofenac, ketorolac, PROLENSA acyclovir cream acyclovir (except acyclovir cream), valacyclovir ADCIRCA sildenafil, tadalafil ADZENYS XR-ODT amphetamine-dextroamphetamine mixed salts ext-rel†, dexmethylphenidate ext-rel, dextroamphetamine ext-rel, methylphenidate ext-rel†, MYDAYIS,
    [Show full text]
  • Epinephrine Auto-Injector
    ELIXIR; Epinephrine Auto-Injector FINAL DESIGN & PRODUCT SPECIFICATION REPORT DNH603_SEM2 Zoe Avgoustakis n8607912 CONTENTS 1. Introduction 2. Final Product Design 2.1 Description 2.2 Usability 2.3 QoI Table / Product Ecosystem 3. Value Proposition , 4. Design Justification 4.1 Mechanism 4.2 Form 4.3 Usability 5. Technical Documentation 5.1 Product Components 5.2 Product Function 5.3 Specifications 5.4 Standards 5.5 B.O.M Technical Drawings DNH603_16se2 : i-move project Epinephrine Auto-injector Zoe Avgoustakis n8607923 0.03mg Adrenaline 1. INTRODUCTION Over the course of this project, imm-you-nity has worked to provide innovative design solutions focused on interactive interfaces and devices to help people be more aware, in control and engaged with their health and wellness. The project aim was to design and develop a new consumer interactive product that would provide a distinct personal experience, improving the user’s management and relationship with their Health & Wellness. The project was specifically focused towards the user’s engagement with allergy conditions. Design investigation accounted for emerging technologies and how this could be applied to enhance the user’s management and interaction with severe allergies and anaphylaxis. Australia has one of the highest reported incidences of food allergies in the world with one in ten people forecasted to develop a food allergy throughout their lives. As those who obtain allergies become more and more prevalent, people are turning to technology for assitance of this issue. The client approached the team in endeavour to develop a product that could assist people with the management and treatment of severe allergy conditions of anaphylaxis.
    [Show full text]
  • 2020 PBD 5 Tier Formulary
    2020 Pharmacy Benefit Dimensions 5 Tier Drug Formulary The following information applies to most members enrolled in a Pharmacy Benefit Dimensions pharmacy plan. Note: If you are reading a printed version of this drug formulary, content may have been updated since it was last printed. For the most up-to-date information, please visit www.pbdrx.com. Drug Formulary Introduction • Generic drugs appear in lower case. Brand name drugs are capitalized. • Preferred generic drugs and a few select brand name drugs are assigned to Tier 1. In most instances, once a generic product is available for which there are no bioequivalence concerns, the brand product is removed from the formulary (not covered), and the generic product is assigned to Tier 1. Certain generic drugs may also be covered in a non-preferred tier when efficacy, safety, or cost factors suggest that better alternatives exist on the formulary. • Pharmacy Benefit Dimensions reserves the right to modify drug tiers as necessary. • Some medications are considered non-formulary (not covered). To obtain a medication that is non-formulary, your health care provider is encouraged to submit a Prior Authorization request for coverage through the exception process. If the request is approved, you will be responsible for the cost share associated with a non- preferred drug tier. • Certain self-funded employer groups may not follow this base formulary and certain exclusions may apply. Members in these pharmacy benefit management groups should refer to their summary plan description and/or their benefit administrator. Prior-Authorization Prior Authorization is required for certain medications. To obtain coverage for a medication requiring Prior Authorization, a Prior Authorization request for medical exception must be submitted by your health care provider and approved by Pharmacy Benefit Dimensions.
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]